Thymidine kinase deletion mutants of bovine herpesvirus-1
AssigneesNovaGene, Inc., Baylor College of Medicine
InventorsMalon Kit, Saul Kit
Life of this patent
Estimating the term…
Abstract
Bovine herpesvirus type 1 (infectious bovine rhinotracheitis virus) mutants which fail to produce any functional thymidine kinase as a result of a deletion in the thymidine kinase gene. The deletion in the thymidine kinase gene attenuates the viruses so that they can be used as an active agent in a modified live-virus vaccine against infectious bovine rhinotracheitis. This invention also relates to methods for the production and use of the same.
Claims25
An infectious bovine rhinotracheitis virus which fails to produce any functional TK as a result of a deletion in the tk gene.
An infectious bovine rhinotracheitis virus which fails to produce any functional TK as a result of a deletion in the tk gene produced by the process comprising:
- (1) constructing a hybrid plasmid comprising a cloning vector and a DNA fragment of IBRV containing substantially all of the IBRV tk gene;
- (2) co-transfecting, in tk.sup.+ host cells, the hybrid plasmid of step (1) with infectious DNA from a tk.sup.- IBRV mutagen-induced mutant;
- (3) selecting, in tk.sup.- host cells, for tk.sup.+ IBRB from the virus produced in step (2);
- (4) deleting DNA sequences from the hybrid plasmid of step (1) such that less than substantially all of the IBRV tk gene is present;
- (5) co-transfecting, in tk.sup.+ host cells, IBRV tk.sup.+ DNA derived from the tk.sup.+ IBRV obtained in step (3) with the resulting tk.sup.- hybrid plasmid of step (4);
- and
- (6) selecting, in tk.sup.- host cells, for tk.sup.- IBRV from the virus produced in step (5) so as to produce tk.sup.- IBRV mutants which fail to produce any functional TK as a result of a deletion in the tk gene.
Dependencies are inferred from the claim text.